Validation of whole blood rapid diagnosis test for hepatitis b

Jose D. Debes, Gertine van Oord, Andre Boonstra

Research output: Contribution to journalLetterpeer-review


We recently published a report validating point-of-care rapid diagnostic tests (RDT) for the diagnosis of Hepatitis B virus (HBV) infection in serum. In the current report, we validated a whole-blood RDT for HBsAg in the form of a test-strip. The test was validated in 55 HBV positive individuals across all geno-types other than F, and in 20 HBV negative individuals in the Netherlands. The RDT showed 100% sensi-tivity and specificity. The low cost and use in whole blood allows this RDT to be useful in resource-limited locations, further validation in such settings will be of importance.

Original languageEnglish (US)
Article number53
JournalAnnals of global health
Issue number1
StatePublished - 2020

Bibliographical note

Funding Information:
This work was supported the Robert Wood Johnson Foundation, AFMDP, Mitialto Foundation and NIH-NCI R21 CA215883-01A1 all to JDD. Funding sponsors had no role in the production of this manuscript.

Fingerprint Dive into the research topics of 'Validation of whole blood rapid diagnosis test for hepatitis b'. Together they form a unique fingerprint.

Cite this